Absci Corp (ABSI) stock
Close on Nov 17, 2026Market cap $1.30BP/E –Yield –
Earnings
Absci's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Absci's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 23, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026before the open | $300.00K | -25.0% | -$0.19 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 11, 2026after the close | $300.00K | -50.0% | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026after the close | $200.00K | -83.3% | -$0.19 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 24, 2026after the close | $700.00K | 0.0% | -$0.20 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025after the close | $400.00K | -76.5% | -$0.20 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 12, 2025after the close | $600.00K | -53.8% | -$0.24 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 13, 2025after the close | $1.20M | +33.3% | -$0.21 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 18, 2025after the close | $700.00K | +133.3% | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024before the open | $1.70M | +142.9% | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 14, 2024after the close | $1.30M | -61.8% | -$0.22 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024before the open | $900.00K | -30.8% | -$0.22 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 21, 2024before the open | $300.00K | -81.3% | -$0.25 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023after the close | $700.00K | -70.8% | -$0.24 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023before the open | $3.40M | +239.3% | -$0.45 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023after the close | $1.30M | +58.7% | -$0.26 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 30, 2023after the close | $1.60M | +6.7% | -$0.21 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 9, 2022before the open | $2.40M | +60.0% | -$0.30 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022before the open | $1.00M | – | -$0.32 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 11, 2022before the open | $819.00K | – | -$0.33 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 22, 2022after the close | $1.50M | – | -$0.28 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 9, 2021before the open | $1.50M | – | -$0.33 | Release |
| Q2 FY2021ended Jun 30, 2021 | Sep 7, 2021before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Absci guided for has been reported
Guidance history
Every forecast Absci put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 12, 2024 | gross use of cash, cash equivalents, and short-term investments | FY2024 | $75.00M | Lowered |
| Aug 14, 2024 | gross use of cash, cash equivalents, and short-term investments | FY2024 | $80.00M | Reaffirmed |
| May 14, 2024 | gross use of cash, cash equivalents, and short-term investments | FY2024 | $80.00M | Reaffirmed |
| Mar 21, 2024 | gross use of cash, cash equivalents, and short-term investments | FY2024 | $80.00M | New |
| Nov 14, 2023 | gross use of cash, cash equivalents, and short-term investments, exclusive of partnered program and equipment financing receipts | FY2023 | $80.00M | Lowered |
| Aug 14, 2023 | gross use of cash, cash equivalents, and short-term investments, exclusive of partnered program and equipment financing receipts | FY2023 | $90.00M | Reaffirmed |
| May 15, 2023 | gross use of cash, cash equivalents, and short-term investments | FY2023 | $90.00M | Reaffirmed |
| Mar 30, 2023 | gross use of cash, cash equivalents, and short-term investments, exclusive of partnered program and equipment financing receipts | FY2023 | $90.00M | New |
| Nov 9, 2022 | net decrease in cash and cash equivalents, short-term investments and restricted cash | FY2022 | $105.00M | Lowered |
| Aug 11, 2022 | net decrease in cash, cash equivalents, and restricted cash | FY2022 | $110.00M | Lowered |
| May 11, 2022 | net decrease in cash, cash equivalents, and restricted cash | FY2022 | $120.00M | Reaffirmed |
| Mar 22, 2022 | capital expenditures | FY2022 | $8.30M | New |
| Mar 22, 2022 | net decrease in cash, cash equivalents, and restricted cash | FY2022 | $120.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Absci filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- News
- News
- Results
- Results
- Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating ResultsResults
- Results
- Update
- News
- Results
- Results
- Results
See a number that looks wrong?